The EULAR and ACR developed evidence-based guidance and points-to-consider for the diagnosis and management of patients with CANDLE/PRAAS, SAVI, and AGS.
A EULAR taskforce developed recommendations regarding lifestyle behaviors and work participation to prevent progression of rheumatic and musculoskeletal diseases among patients.
The American College of Rheumatology (ACR) developed updated guidelines for the pharmacologic management of juvenile idiopathic arthritis, with a focus on treatment of oligoarthritis, temporomandibular joint arthritis, and systemic JIA.
A EULAR task force recently developed recommendations for the management of cardiovascular risk in patients with rheumatic and musculoskeletal diseases, including gout, lupus, and systemic sclerosis.
Researchers assessed the difference in autoantibody response between men and women with previous SARS-CoV-2 infection.
Researchers evaluated the effect of intensive serum urate-lowering therapy on bone erosion scores in erosive gout.
Researchers studied the association between reproductive factors and the incidence of gout, using data from a cohort of postmenopausal women.
A 12-year-old Japanese girl with Williams syndrome and osteoporosis presented with very low bone mineral density and received treatment with denosumab.
Based on the most recent available literature, the EULAR updated the points-to-consider on using immunomodulatory therapies in COVID-19, from a rheumatology perspective.
Researchers assessed the immune response of patients with rheumatoid arthritis and seronegative spondyloarthritis to mRNA COVID-19 vaccination after the first and second dose.
